Home › Compare › EXSPF vs BTI

EXSPF vs BTI: Dividend Comparison 2026

EXSPF yields 99.50% · BTI yields 5.40%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EXSPF wins by $3.78M in total portfolio value
10 years
EXSPF
EXSPF
● Live price
99.50%
Share price
$2.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3.82M
Annual income
$1,282,231.48
Full EXSPF calculator →
BTI
BTI
● Live price
5.40%
Share price
$58.26
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.8K
Annual income
$2,802.29
Full BTI calculator →

Portfolio growth — EXSPF vs BTI

📍 EXSPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEXSPFBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EXSPF + BTI cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
EXSPF pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EXSPF
Annual income on $10K today (after 15% tax)
$8,457.71/yr
After 10yr DRIP, annual income (after tax)
$1,089,896.76/yr
BTI
Annual income on $10K today (after 15% tax)
$459.05/yr
After 10yr DRIP, annual income (after tax)
$2,381.95/yr
At 15% tax rate, EXSPF beats the other by $1,087,514.81/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EXSPF + BTI for your $10,000?

EXSPF: 50%BTI: 50%
100% BTI50/50100% EXSPF
Portfolio after 10yr
$1.93M
Annual income
$642,516.88/yr
Blended yield
33.33%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

EXSPF
No analyst data
Altman Z
1.3
Piotroski
5/9
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.3% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EXSPF buys
0
BTI buys
0
No recent congressional trades found for EXSPF or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEXSPFBTI
Forward yield99.50% ✓5.40%
Annual dividend / share$2.00$3.15 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%11.3% ✓
Portfolio after 10y$3.82M$37.8K ✓
Annual income after 10y$1,282,231.48 ✓$2,802.29
Total dividends collected$3.41M$14.4K ✓
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: EXSPF vs BTI ($10,000, DRIP)

YearEXSPF PortfolioEXSPF Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$20,650$9,950.25$11,301$601.08+$9.3K → EXSPF
2$41,299$19,203.28$12,799$706.58+$28.5K → EXSPF
3$80,083$35,892.72$14,527$832.38+$65.6K → EXSPF
4$150,735$65,046.11$16,527$982.75+$134.2K → EXSPF
5$275,709$114,422.60$18,846$1,162.95+$256.9K → EXSPF
6$490,607$195,598.45$21,545$1,379.49+$469.1K → EXSPF
7$850,235$325,285.52$24,694$1,640.41+$825.5K → EXSPF
8$1,436,600$526,849.17$28,378$1,955.69+$1.41M → EXSPF
9$2,369,117$831,954.65$32,702$2,337.79+$2.34M → EXSPF
10$3,817,187$1,282,231.48$37,794$2,802.29+$3.78M → EXSPF

EXSPF vs BTI: Complete Analysis 2026

EXSPF — Stock

Expert.ai S.p.A., an artificial intelligence (AI) platform company, develops and sells cognitive computing software products based on AI algorithms to read and understand written language worldwide. The company offers expert.ai Platform that captures the strategic value of language data; expert.ai Answers, a customer support automation software that allows human like interaction between customers and internal staff, using the language of business and users; expert.ai Discover, a text analytics, and extraction and categorization software; expert.ai for Insurance that automate insurance claims management with natural language understanding; and expert.ai for Life Sciences to mimic the human like comprehension of scientific content, such as publications, patents, clinical trials, or medical reports. It serves the banking and insurance, public administration, life science and pharma, oil and gas, media and publishing, and telecom and utilities industries, as well as defense, and intelligence and law enforcement industries. Expert.ai S.p.A. has a strategic partnership agreement with WealthIntel Inc. to facilitate innovations in natural language and text analytics. The company was formerly known as Expert System S.p.A. and changed its name to Expert.ai S.p.A. in May 2021. Expert.ai S.p.A. was founded in 1989 and is headquartered in Modena, Italy.

Full EXSPF Calculator →

BTI — Consumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this EXSPF vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EXSPF vs SCHDEXSPF vs JEPIEXSPF vs OEXSPF vs KOEXSPF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.